Induct ASOSL:INDCT -1.37%53 EBITDA Margin % is 26.53% as of Mar. 2026. GuruFocus rates OSL:INDCT with a GF Score™ of 53/100 and a GF Value™ of kr2.28 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Induct AS ranks better than 95.96% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Induct AS's EBITDA for the
three
months ended in Mar. 2026 was kr0.87 Mil. Induct AS's Revenue for the
three
months ended in Mar. 2026 was kr3.26 Mil. Therefore, Induct AS's EBITDA margin for the quarter that ended in Mar. 2026 was 26.53%.
Induct AS (OSL:INDCT) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Induct AS EBITDA Margin % Related Terms
Induct AS EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Induct AS's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:INDCT vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, Induct AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Induct AS EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Induct AS's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Induct AS's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Induct AS (OSL:INDCT) has a EBITDA Margin % of 26.53% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Induct AS and its competitors. According to the industry distribution chart, Induct AS ranks #27 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is Induct AS's EBITDA Margin % too high?
Induct AS's current EBITDA Margin % is 26.53%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Induct AS's value of 26.53% is 159.8% above this industry median. Based on the distribution chart, Induct AS ranks #27 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Induct AS has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Induct AS's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Induct AS ranks #27 out of 668 companies for EBITDA Margin %. This places Induct AS in the top 4% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Induct AS's value of 26.53% is 159.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Induct AS's current EBITDA Margin % of 26.53% is 159.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Induct AS and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Induct AS's current EBITDA Margin % is 26.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Induct AS stock overvalued right now?
Based on GuruFocus' analysis, Induct AS (OSL:INDCT) is currently considered Possible Value Trap. The stock's GF Value™ is kr2.28, compared to a current price of kr1.08 — trading 52.6% below its estimated fair value. The current EBITDA Margin % is 26.53% and 159.8% above the Healthcare Providers & Services industry median of 10.21. Induct AS's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Induct AS (OSL:INDCT), the current EBITDA Margin % is 26.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Induct AS (OSL:INDCT) Overvalued in 2026?
Based on GuruFocus' analysis, Induct AS stock appears to be undervalued.
The current stock price of kr1.08 is trading 52.6% below its estimated GF Value™ of kr2.28.
GuruFocus considers Induct AS to be Possible Value Trap.
Key valuation signals for OSL:INDCT:
EBITDA Margin %: 26.53%
GF Value™: kr2.28 vs. price of kr1.08 (52.6% below fair value)
Industry Position: 159.8% above the Healthcare Providers & Services median (#27 of 668)
No single metric tells the full story. See the OSL:INDCT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Induct AS is engaged in the business of software development. It offers a digital platform for work and collaboration, for individuals, Homes, Organizations, and Work.
53GF Score
Get the complete analysis for OSL:INDCT
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:INDCT has been successfully added to your 
